Clinical Trial Update: Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Flu/TBI for prostate cancer patients not responding to prior hormone therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN